PLSE Long Call Strategy
PLSE (Pulse Biosciences, Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
PLSE (Pulse Biosciences, Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $1.63B, a beta of 1.63 versus the broader market, a 52-week range of 12.56-26.3, average daily share volume of 299K, a public-listing history dating back to 2016, approximately 75 full-time employees. These structural characteristics shape how PLSE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.63 indicates PLSE has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long call on PLSE?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current PLSE snapshot
As of May 15, 2026, spot at $24.66, ATM IV 71.20%, IV rank 5.58%, expected move 20.41%. The long call on PLSE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on PLSE specifically: PLSE IV at 71.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a PLSE long call, with a market-implied 1-standard-deviation move of approximately 20.41% (roughly $5.03 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PLSE expiries trade a higher absolute premium for lower per-day decay. Position sizing on PLSE should anchor to the underlying notional of $24.66 per share and to the trader's directional view on PLSE stock.
PLSE long call setup
The PLSE long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PLSE near $24.66, the first option leg uses a $25.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PLSE chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PLSE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $25.00 | $2.60 |
PLSE long call risk and reward
- Net Premium / Debit
- -$260.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$260.00
- Breakeven(s)
- $27.60
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
PLSE long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on PLSE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$260.00 |
| $5.46 | -77.9% | -$260.00 |
| $10.91 | -55.7% | -$260.00 |
| $16.36 | -33.6% | -$260.00 |
| $21.82 | -11.5% | -$260.00 |
| $27.27 | +10.6% | -$33.32 |
| $32.72 | +32.7% | +$511.81 |
| $38.17 | +54.8% | +$1,056.95 |
| $43.62 | +76.9% | +$1,602.09 |
| $49.07 | +99.0% | +$2,147.22 |
When traders use long call on PLSE
Long calls on PLSE express a bullish thesis with defined risk; traders use them ahead of PLSE catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
PLSE thesis for this long call
The market-implied 1-standard-deviation range for PLSE extends from approximately $19.63 on the downside to $29.69 on the upside. A PLSE long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current PLSE IV rank near 5.58% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PLSE at 71.20%. As a Healthcare name, PLSE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PLSE-specific events.
PLSE long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PLSE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PLSE alongside the broader basket even when PLSE-specific fundamentals are unchanged. Long-premium structures like a long call on PLSE are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current PLSE chain quotes before placing a trade.
Frequently asked questions
- What is a long call on PLSE?
- A long call on PLSE is the long call strategy applied to PLSE (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With PLSE stock trading near $24.66, the strikes shown on this page are snapped to the nearest listed PLSE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PLSE long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the PLSE long call priced from the end-of-day chain at a 30-day expiry (ATM IV 71.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$260.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PLSE long call?
- The breakeven for the PLSE long call priced on this page is roughly $27.60 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PLSE market-implied 1-standard-deviation expected move is approximately 20.41%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on PLSE?
- Long calls on PLSE express a bullish thesis with defined risk; traders use them ahead of PLSE catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current PLSE implied volatility affect this long call?
- PLSE ATM IV is at 71.20% with IV rank near 5.58%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.